1. 71OPhase I extension study of ETC-159 an oral PORCN inhibitor administered with bone protective treatment, in patients with advanced solid tumours. (25th November 2018) Authors: Tan, D; Ng, M; Subbiah, V; Messersmith, W; Teneggi, V; Diermayr, V; Ethirajulu, K; Yeo, P; Gan, B H; Lee, L H; Blanchard, S; Nellore, R; Yasin, M; Umrani, D; Lee, M A; Hill, J; Madan, B; Virshup, D; Matter, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗